189 related articles for article (PubMed ID: 4761908)
21. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
[TBL] [Abstract][Full Text] [Related]
22. Plasma insulin in disorders of carbohydrate metabolism.
Salamonsen LA; Smith JR; Arcus AC; Espiner EA; Beaven DW
N Z Med J; 1969 Oct; 70(449):231-8. PubMed ID: 4313498
[No Abstract] [Full Text] [Related]
23. A contribution to the interpretation of the oral glucose tolerance (OGTT).
Karp M; Brown M; Laron Z
Diabetologia; 1972 Dec; 8(6):381-4. PubMed ID: 4647715
[No Abstract] [Full Text] [Related]
24. Effects of a high-carbohydrate diet on blood glucose, insulin and triglyceride levels in normal and obese subjects and in obese subjects with impaired glucose tolerance.
Silva ME; Pupo AA; Ursich MJ
Braz J Med Biol Res; 1987; 20(3-4):339-50. PubMed ID: 3330460
[TBL] [Abstract][Full Text] [Related]
25. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
26. A prospective study of glucose profiles, insulin antibody levels and beta cells secretory patterns in non-obese Ugandan diabetic subjects.
Otim MA
East Afr Med J; 1988 Jan; 65(1):8-15. PubMed ID: 3046922
[No Abstract] [Full Text] [Related]
27. Glucose metabolism during the starved-to-fed transition in obese patients with NIDDM.
Féry F; Balasse EO
Diabetes; 1994 Dec; 43(12):1418-25. PubMed ID: 7958493
[TBL] [Abstract][Full Text] [Related]
28. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
[TBL] [Abstract][Full Text] [Related]
29. Diabetes in remission. Insulin secretory dynamics.
Park BN; Gleason RE; Soeldner JS
Diabetes; 1974 Jul; 23(7):616-23. PubMed ID: 4858339
[No Abstract] [Full Text] [Related]
30. [Plasma glucagon and insulin profile in obese non-diabetic and non-insulin-dependent diabetic patients on a daily 800 calorie diet].
Balázsi I; Varsányi-Nagy M; Nagy K
Orv Hetil; 1986 Aug; 127(33):2009-13. PubMed ID: 3537903
[No Abstract] [Full Text] [Related]
31. The occurrence of low insulin response to glucose infusion in children.
Cerasi E; Luft R
Diabetologia; 1970 Apr; 6(2):85-9. PubMed ID: 4912301
[No Abstract] [Full Text] [Related]
32. [Plasma levels of beta-endorphin in obese subjects with normal glucose tolerance test and in diabetics].
Donatelli M; Terrizzi C; Russo V; Bucalo ML; Scarpinato A; Verga S; Puglisi S; Miceli G; Iraci T; Bompiani GD
Recenti Prog Med; 1991 Jan; 82(1):1-3. PubMed ID: 2028070
[TBL] [Abstract][Full Text] [Related]
33. Endogenous insulin secretion in newly diagnosed diabetic patients in Saudi Arabia.
al-Attas OS; Laajam MA; Khan MS; al-Dress AZ
Diabetes Res Clin Pract; 1990 Jan; 8(1):51-9. PubMed ID: 2404726
[TBL] [Abstract][Full Text] [Related]
34. [Insulin secretion and beta-adrenergic blockade in normal subjects, obese subjects and obese diabetics after carbohydrate stimulation].
Saitta A; Quartarone M; Cucinotta D; Mangano C; Pizzoleo MA; Squadrito G
Minerva Med; 1979 May; 70(22):1611-5. PubMed ID: 36579
[No Abstract] [Full Text] [Related]
35. [Glucagon mediated insulin release in man].
Marks V; Salmols E
Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():285-308. PubMed ID: 4907221
[No Abstract] [Full Text] [Related]
36. Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations.
Nyholm B; Walker M; Gravholt CH; Shearing PA; Sturis J; Alberti KG; Holst JJ; Schmitz O
Diabetologia; 1999 Nov; 42(11):1314-23. PubMed ID: 10550415
[TBL] [Abstract][Full Text] [Related]
37. Plasma level of glucagon-like peptide 1 in obese Egyptians with normal and impaired glucose tolerance.
Hussein MS; Abushady MM; Refaat S; Ibrahim R
Arch Med Res; 2014 Jan; 45(1):58-62. PubMed ID: 24321596
[TBL] [Abstract][Full Text] [Related]
38. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
[TBL] [Abstract][Full Text] [Related]
39. [Assessment of the B-cell function in diabetic patients by means of the determination of insulin secretion following glucose-tolbutamide stimulation].
Jahnke KA; Reis HE; Jahnke K
Med Welt; 1976 Nov; 27(47):2293-5. PubMed ID: 794618
[No Abstract] [Full Text] [Related]
40. Metabolic and hormonal patterns after three days of total fasting in 27 obese and nonobese subjects.
Tiengo A; Assan R; Tchobroutsky G
Isr J Med Sci; 1972 Jun; 8(6):821-2. PubMed ID: 5051804
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
